Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01343316 · ClinicalTrials.gov registry record
Benefits of Post-Pyloric Feeding Tubes in Critically Ill Patients
A clinical trial, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- 21
- Enrollment target
NCT01343316: Clinical Trial study, sponsored by Johns Hopkins University.
NCT01343316 is a clinical trial that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01343316 was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the benefit of feeding critically-ill patients beyond the stomach (post-pyloric). Furthermore, because of the advent of two new post-pyloric feeding tubes (Tiger 2 and Syncro BlueTube) designed to improve post-pyloric placement, the investigators will be evaluating the benefits of those two tubes as well.
Interventions
- DEVICE Transpyloric feeding tubes (Nasogastric Tube (NG tube), Tiger2, Syncro BlueTube)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2010-11 |
| Est. Completion | 2013-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01343316
The ClinicalTrials.gov registry entry for NCT01343316 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transpyloric feeding tubes (Nasogastric Tube (NG tube), Tiger2, Syncro BlueTube) is the first listed.
NCT01343316 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01343316 about?
NCT01343316 is a clinical study titled "Benefits of Post-Pyloric Feeding Tubes in Critically Ill Patients". The purpose of this study is to determine the benefit of feeding critically-ill patients beyond the stomach (post-pyloric). Furthermore, because of the advent of two new post-pyloric feeding tubes (Tiger 2 and Syncro BlueTube) designed to improve post-pyloric placement, the investigators will be eva...
What is the current status of trial NCT01343316?
This trial is currently terminated. The enrollment target is 21 participants. The study started on 2010-11. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01343316?
The interventions under investigation include: Transpyloric feeding tubes (Nasogastric Tube (NG tube), Tiger2, Syncro BlueTube) (DEVICE).
Who is sponsoring clinical trial NCT01343316?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.